Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 1.000 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.573 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.568 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.567 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.554 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.541 | |
| 4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.537 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.535 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.535 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.530 | |
| 3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.527 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.526 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.526 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.525 | |
| 3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.524 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.524 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.524 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.522 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.521 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.520 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.520 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.517 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.517 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.515 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.515 | |
| 1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.514 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.513 | |
| 1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.512 | |
| 2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.512 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.512 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.509 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.505 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.505 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.504 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.503 | |
| 1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.503 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.503 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.503 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.502 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.502 | |
| 3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.502 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.501 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.501 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.500 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.499 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.499 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.498 | |
| 4j98 | ACP | Fibroblast growth factor receptor 2 | / | 0.498 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.497 | |
| 4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.497 | |
| 1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.496 | |
| 3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.496 | |
| 4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.496 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.496 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.495 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.495 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
| 2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.494 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
| 3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.493 | |
| 4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.493 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.492 | |
| 1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
| 1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.491 | |
| 2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.490 | |
| 2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.490 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.490 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.489 | |
| 4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.489 | |
| 4im0 | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.489 | |
| 4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.489 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
| 5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.488 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.487 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.487 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.487 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.486 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.486 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.486 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.485 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.485 | |
| 1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.484 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.484 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.484 | |
| 3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.484 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.484 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.484 | |
| 1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.483 | |
| 2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
| 2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.483 | |
| 3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.482 | |
| 3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.482 | |
| 3d7t | STU | Tyrosine-protein kinase CSK | / | 0.482 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.482 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.482 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.482 | |
| 2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.481 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.481 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.481 | |
| 4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
| 4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
| 4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.480 | |
| 4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.479 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.478 | |
| 2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.478 | |
| 4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.478 | |
| 2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.477 | |
| 4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.477 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.477 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.476 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.476 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.476 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.476 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.476 | |
| 4oh4 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.476 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.476 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.475 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.475 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
| 4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.475 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.475 | |
| 2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.474 | |
| 2zv2 | 609 | Calcium/calmodulin-dependent protein kinase kinase 2 | 2.7.11.17 | 0.474 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
| 2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.473 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.473 | |
| 2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.473 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.472 | |
| 4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.472 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.472 | |
| 4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.472 | |
| 2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.471 | |
| 2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.471 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.471 | |
| 4im2 | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.471 | |
| 4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.471 | |
| 5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.471 | |
| 3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.470 | |
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
| 4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
| 1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
| 1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
| 1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
| 2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.469 | |
| 2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.469 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.469 | |
| 3uli | 1N3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
| 4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 2xng | A0H | Aurora kinase A | 2.7.11.1 | 0.468 | |
| 4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.468 | |
| 2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.467 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.467 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.467 | |
| 3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.467 | |
| 4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.467 | |
| 4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.466 | |
| 4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.466 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.466 | |
| 4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.466 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.466 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.466 | |
| 2pvm | P29 | Casein kinase II subunit alpha | 2.7.11.1 | 0.465 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.465 | |
| 3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.465 | |
| 5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.465 | |
| 2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.464 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.464 | |
| 3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
| 3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.464 | |
| 4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.464 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
| 4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.464 | |
| 1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.463 | |
| 1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.463 | |
| 4ji9 | 1M3 | Tyrosine-protein kinase JAK2 | / | 0.463 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
| 2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.462 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
| 4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.462 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.462 | |
| 4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
| 4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.461 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.461 | |
| 3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.461 | |
| 4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.461 | |
| 4i0r | 1B4 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.461 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.461 | |
| 1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
| 1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.460 | |
| 1q99 | ANP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.460 | |
| 2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.460 | |
| 2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.460 | |
| 4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
| 2cgv | 3B3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.459 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.459 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.459 | |
| 3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.459 | |
| 4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.458 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.458 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.458 | |
| 3llt | ANP | Protein serine/threonine kinase-1 | / | 0.458 | |
| 3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.458 | |
| 3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.458 | |
| 4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.458 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.458 | |
| 1snu | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.457 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.457 | |
| 2vtq | LZA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.457 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.457 | |
| 3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.457 | |
| 4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.457 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.457 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
| 5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.457 | |
| 5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.457 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.456 | |
| 2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
| 3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.456 | |
| 4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
| 4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.456 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.456 | |
| 4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.456 | |
| 4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 0.456 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.456 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.455 | |
| 3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.455 | |
| 3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.455 | |
| 3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.455 | |
| 4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
| 2yaa | ATP | Death-associated protein kinase 2 | / | 0.454 | |
| 3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
| 3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
| 3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
| 3w0s | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.454 | |
| 4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.454 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.454 | |
| 4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.454 | |
| 1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.453 | |
| 2buj | STU | Serine/threonine-protein kinase 16 | / | 0.453 | |
| 2cke | IQU | Death-associated protein kinase 2 | / | 0.453 | |
| 2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.453 | |
| 2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
| 4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.453 | |
| 4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.453 | |
| 4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.453 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.452 | |
| 1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.452 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.452 | |
| 2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 3at3 | ATK | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
| 3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.452 | |
| 3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.452 | |
| 3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.452 | |
| 4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.452 | |
| 4f08 | 1RS | Tyrosine-protein kinase JAK2 | / | 0.452 | |
| 4fta | H5K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.452 | |
| 4ix6 | ADP | Uncharacterized protein | / | 0.452 | |
| 2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.451 | |
| 2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 3p23 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.451 | |
| 3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
| 4mf1 | 29Y | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.451 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.451 | |
| 5c8w | PCG | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.451 | |
| 1cde | GAR | Phosphoribosylglycinamide formyltransferase | / | 0.450 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.450 | |
| 1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.450 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.450 | |
| 3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
| 4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.450 | |
| 4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
| 4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 4mcb | 21W | tRNA (guanine-N(1)-)-methyltransferase | 2.1.1.228 | 0.450 | |
| 1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.449 | |
| 1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.449 | |
| 1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
| 2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.449 | |
| 2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.449 | |
| 2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.449 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.449 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.449 | |
| 4bcn | T9N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 4fsm | HK1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 4o0s | ADN | Aurora kinase A | 2.7.11.1 | 0.449 | |
| 4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.449 | |
| 1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.448 | |
| 2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
| 3pre | 3RE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.448 | |
| 4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.448 | |
| 4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 4w9w | YDJ | BMP-2-inducible protein kinase | 2.7.11.1 | 0.448 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
| 2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.447 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.447 | |
| 4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.447 | |
| 4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.447 | |
| 4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
| 4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.447 | |
| 4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 4wsq | KSA | AP2-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.447 | |
| 1urw | I1P | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 1ykr | 628 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.446 | |
| 2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
| 2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 2yyi | FAD | 4-hydroxyphenylacetate 3-monooxygenase oxygenase component | 1.14.14.9 | 0.446 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
| 4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.446 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.446 | |
| 1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
| 1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.445 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.445 | |
| 2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.445 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.445 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.445 | |
| 2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
| 3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.445 | |
| 3vw6 | IM6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.445 | |
| 3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.445 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.445 | |
| 4ewh | T77 | Activated CDC42 kinase 1 | / | 0.445 | |
| 4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.445 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.445 | |
| 1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.444 | |
| 3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.444 | |
| 3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 1e8w | QUE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 1nxk | STU | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.443 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.443 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.443 | |
| 2q7v | FAD | Thioredoxin reductase | / | 0.443 | |
| 2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
| 3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.443 | |
| 4bgh | 3I6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.443 | |
| 4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
| 4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
| 4ivb | 1J5 | Tyrosine-protein kinase JAK1 | / | 0.443 | |
| 4oti | MI1 | Serine/threonine-protein kinase N1 | / | 0.443 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
| 5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.443 | |
| 1bxo | PP7 | Penicillopepsin-1 | 3.4.23.20 | 0.442 | |
| 1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 2uw0 | GVK | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.442 | |
| 3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.442 | |
| 3uim | ANP | BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 | 2.7.10.1 | 0.442 | |
| 4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.442 | |
| 4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
| 4gii | 0X6 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.442 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.442 | |
| 1me7 | MOA | Inosine-5'-monophosphate dehydrogenase | / | 0.441 | |
| 2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.441 | |
| 2uzd | C85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 2uzt | SS3 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
| 3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3rmf | 20Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.441 | |
| 4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.441 | |
| 1bws | NDP | GDP-L-fucose synthase | / | 0.440 | |
| 2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.440 | |
| 2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 2v4l | ABJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
| 2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 2wip | P49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.440 | |
| 3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.440 | |
| 4fto | 3HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.440 | |
| 4iva | 1J5 | Tyrosine-protein kinase JAK2 | / | 0.440 | |
| 4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.440 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.440 | |
| 4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.440 | |
| 5a4k | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.440 | |
| 5dt0 | SKE | Aurora kinase A | 2.7.11.1 | 0.440 |